Back to Journals » Drug Design, Development and Therapy » Volume 16

Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data

Total article views   HTML views PDF downloads Totals
5,922 Dovepress* 4,419+ 543 4,962
PubMed Central* 1,503 326 1,829
Totals 5,922 869 6,791
*Since 10 November 2022

View citations on PubMed and Google Scholar